← Leaderboards
Veronika S Bachanova
University Of Minnesota
$578,530
Attributed
$770,880
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $592.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$770,880 · 3
By mechanism
P01$384,716 · 1
R21$384,701 · 1
M01$1,463 · 1
Top collaborators
- Serguei Vs Pakhomov2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Branden S Moriarity$9,306,595
- Jeffrey S Miller$32,066,338
- Pamela J Skinner$13,080,684
- Gabrielle Matilde Robbins$162,965
- Melissa Ann Geller$2,938,539
Others in their field
Top investigators on “Infusion Procedures”
- Myron S Cohen · Family Health International$91,263,426
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Georgia D Tomaras · Fred Hutchinson Cancer Center$70,233,271
- Dan H. Barouch · Fred Hutchinson Cancer Center$63,804,365
- Lawrence Corey · Fred Hutchinson Cancer Center$58,962,452
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,962,452
Research focus
Infusion ProceduresExhibitsImmuneSpecificityImmunotherapyDosePreventCancer TherapyClinical ResearchChimeric Antigen Receptor T CellsResponseClinical TrialsAssociated SymptomAllogenicCognitive TestingClinical ProtocolsCognitiveComaArtificial IntelligenceCessation Of LifeAffectBrain EdemaChatbotClassification
Grant awards (4)
Off-The-Shelf Dual Targeted NK Cells For NHL$384,716
P01 · FY2025 · CA · contact PI
Improving safety and access to immune effector cell therapy with artificial intelligence technology$207,895
R21 · FY2025 · CA · contact PI
Improving safety and access to immune effector cell therapy with artificial intelligence technology$176,806
R21 · FY2024 · CA · contact PI
MT2007-12: ALLOGENEIC NATURAL KILLER CELLS WITH RITUXIMAB IN PATIENTS WITH CD20$1,463
M01 · FY2009 · RR · contact PI